Principal Financial Group
AYTU icon

Principal Financial Group’s AYTU BioPharma AYTU Stock Holding History

Principal Financial Group’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,128
Closed -$323K – 2602
2021
Q1 		$323K Buy
2,128
+162
+8% +$25.7K ﹤0.01% 2257
2020
Q4 		$235K Buy
+1,966
New +$358K ﹤0.01% 2283

Other funds holding AYTU

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Principal Financial Group's AYTU Position: Q2 2021 in Review

Principal Financial Group sold out of AYTU BioPharma (AYTU) in Q2 2021, closing a stake of 2,128 shares — an estimated $323K sold.

Principal Financial Group first reported a position in AYTU in Q4 2020 and held it in 2 quarters. The position peaked at $323K in Q1 2021. 50 funds tracked by Wall St. Rank hold AYTU as of Q2 2021.

  • Principal Financial Group reported no remaining AYTU BioPharma position as of Q2 2021 after selling out during the quarter.
  • Principal Financial Group sold 2,128 AYTU BioPharma shares in Q2 2021, an estimated $323K.
  • Principal Financial Group first reported a position in AYTU BioPharma in Q4 2020 and held it in 2 quarters.
  • Principal Financial Group's AYTU BioPharma position peaked at $323K in Q1 2021.
  • 50 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2021.

Based on Principal Financial Group's 13F filing for Q2 2021, filed 10 Aug 2021.